By contrast, MET amplification was barely detectable in patients with HCC who underwent resection: 4.5% by SNP genotyping array (Illumina), defined as a copy number ≥3, and 2.3% by FISH (Abbott Molecular), defined as MET/CEP7 ≥2.0 [42, 43]. This evidence concerns the gene MET and hepatocellular carcinoma.